| scholarly article | Q13442814 |
| P50 | author | Marina Saresella | Q56816795 |
| Federica Piancone | Q57206990 | ||
| Ivana Marventano | Q79637658 | ||
| Marco Rovaris | Q83810349 | ||
| P2093 | author name string | Mario Clerici | |
| Laura Mendozzi | |||
| Domenico Caputo | |||
| Francesca La Rosa | |||
| Maria Antonia Santangelo | |||
| P2860 | cites work | Advances in T Helper 17 Cell Biology: Pathogenic Role and Potential Therapy in Multiple Sclerosis | Q26771957 |
| Interleukin 18 (IL-18) as a target for immune intervention | Q28068555 | ||
| Gout-associated uric acid crystals activate the NALP3 inflammasome | Q28131797 | ||
| Serum uric acid and multiple sclerosis | Q28275324 | ||
| Cryopyrin activates the inflammasome in response to toxins and ATP | Q28291313 | ||
| The NALP3 inflammasome is involved in the innate immune response to amyloid-beta | Q29615595 | ||
| Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis. | Q34059225 | ||
| Uric acid in relapsing-remitting multiple sclerosis: a 2-year longitudinal study | Q34462274 | ||
| Serum uric acid levels of patients with multiple sclerosis and other neurological diseases | Q34583852 | ||
| Increase of uric acid and purine compounds in biological fluids of multiple sclerosis patients | Q34606170 | ||
| Inflammasomes and autoimmunity | Q34670542 | ||
| Heterogeneity versus homogeneity of multiple sclerosis | Q34893931 | ||
| Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary study | Q35454481 | ||
| Caspase-8 as an Effector and Regulator of NLRP3 Inflammasome Signaling | Q35953090 | ||
| Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand | Q35957193 | ||
| Interferon-β therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome | Q36431053 | ||
| NLRP3 Inflammasome and MS/EAE. | Q36566053 | ||
| NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses | Q36670359 | ||
| Expression of IL-1β in rhesus EAE and MS lesions is mainly induced in the CNS itself | Q36976299 | ||
| Interleukin-18 and IL-18 binding protein | Q37220336 | ||
| A Fluorescent Reporter Mouse for Inflammasome Assembly Demonstrates an Important Role for Cell-Bound and Free ASC Specks during In Vivo Infection. | Q37741862 | ||
| T cell-intrinsic ASC critically promotes T(H)17-mediated experimental autoimmune encephalomyelitis | Q37744165 | ||
| Interleukin-18, from neuroinflammation to Alzheimer's disease. | Q37823910 | ||
| Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. | Q37845414 | ||
| Serum uric acid levels in patients with multiple sclerosis: a meta-analysis | Q37983970 | ||
| A basic overview of multiple sclerosis immunopathology | Q38587668 | ||
| Serum metabolic profile in multiple sclerosis patients | Q38756394 | ||
| Soluble Uric Acid Activates the NLRP3 Inflammasome. | Q38770923 | ||
| Serum levels of interleukin (IL)-18, IL-23 and IL-17 in Chinese patients with multiple sclerosis | Q39666226 | ||
| Increased expression of caspase-1 and interleukin-18 in peripheral blood mononuclear cells in patients with multiple sclerosis. | Q40477272 | ||
| Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation | Q40891679 | ||
| T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis | Q43457921 | ||
| Augmented type 1 cytokines and human endogenous retroviruses specific immune responses in patients with acute multiple sclerosis | Q44418280 | ||
| Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis | Q46121594 | ||
| ASC controls IFN-γ levels in an IL-18-dependent manner in caspase-1-deficient mice infected with Francisella novicida | Q47703279 | ||
| Multiple sclerosis: cytokine receptors on oligodendrocytes predict innate regulation | Q48101693 | ||
| Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury. | Q48515139 | ||
| Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis. | Q48586779 | ||
| IL-18 in patients with multiple sclerosis | Q48795988 | ||
| Uric acid levels in sera from patients with multiple sclerosis. | Q48929988 | ||
| Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease | Q57911977 | ||
| The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy | Q60981654 | ||
| Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis | Q68043629 | ||
| Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis | Q70114371 | ||
| Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand | Q73035541 | ||
| Production of IL-1beta and IL-1Ra as risk factors for susceptibility and progression of relapse-onset multiple sclerosis | Q74136791 | ||
| Increased serum levels of interleukin-18 in patients with multiple sclerosis | Q74250754 | ||
| Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity | Q74570667 | ||
| IL-18 is linked to raised IFN-gamma in multiple sclerosis and is induced by activated CD4(+) T cells via CD40-CD40 ligand interactions | Q77963029 | ||
| Serum uric acid level in patients with relapsing-remitting multiple sclerosis | Q86488871 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | multiple sclerosis | Q8277 |
| inflammasome complex | Q412405 | ||
| primary progressive multiple sclerosis | Q18553470 | ||
| P304 | page(s) | 983 | |
| P577 | publication date | 2018-05-04 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Monosodium Urate Crystals Activate the Inflammasome in Primary Progressive Multiple Sclerosis | |
| P478 | volume | 9 |
| Q90055129 | Imaging Flow Cytometry Protocols for Examining Phagocytosis of Microplastics and Bioparticles by Immune Cells of Aquatic Animals | cites work | P2860 |
Search more.